首页 > 市场调查报告书 > 医疗设备

医学影像诊断分子呈像/呈影剂

市场调查报告书

商品编码

1447883

全球造影剂市场规模、份额、成长分析，按应用（医院、诊所）、按产品（碘造影剂、微泡造影剂）、按模式（超音波、X 光/CT） - 产业预测 2024-2031

Global Contrast Agents Market Size, Share, Growth Analysis, By Application(Hospitals, Clinics), By Product(Iodinated Contrast Media, Microbubble Contrast Media), By Modality(Ultrasound, X-ray/CT) - Industry Forecast 2024-2031

出版日期: 2024年02月29日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球造影剂市场规模为52.2亿美元，预计将从2023年的53.6亿美元成长到2031年的66.4亿美元，预测期内（2024-2031年）复合CAGR为2.71%。

全球造影剂市场是医学影像领域一个充满活力的领域，其特点是稳定成长和技术进步。造影剂在诊断影像过程中增强体内结构的可视性方面发挥关键作用，从而促进各个医学专业的准确诊断和治疗计划。根据最近的分析，该市场经历了显着扩张，主要是由于慢性病盛行率不断上升、人口老化以及对先进诊断技术的需求不断增长。此外，造影剂配方的持续创新，例如开发更安全、更有效且副作用最小的造影剂，进一步推动了市场成长。值得注意的是，市场格局也受到不断发展的监管框架和医疗保健政策的影响，影响产品审批、市场进入策略和竞争动态。在各个地理区域中，造影剂市场呈现出不均匀的成长模式，北美和欧洲等已开发经济体由于其强大的医疗基础设施、高医疗支出和先进成像技术的早期采用而占据了大量市场份额。相反，在改善医疗基础设施、增加可支配收入和增加医疗投资的推动下，亚太和拉丁美洲的新兴经济体为市场扩张提供了利润丰厚的机会。然而，定价压力、严格的监管要求以及替代成像方式的出现等挑战给市场参与者带来了重大障碍，需要策略合作、产品差异化和市场渗透策略来保持竞争力和维持成长。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

Bayer AG
General Electric Company
Guerbet
Bracco Diagnostic, Inc.
Nano Therapeutics Pvt. Ltd.
Lantheus Medical Imaging, Inc.
iMax
Trivitron Healthcare
GE Healthcare
Hengrui Medicine
YRPG
BeiLu Pharma
JB Chemicals and Pharmaceuticals Ltd.
Unijules Life Sciences Ltd.
SANOCHEMIA Pharmazeutika GmbH
Taejoon Pharm

简介目录

Product Code: SQMIG15A2297

Global Contrast Agents Market size was valued at USD 5.22 billion in 2022 and is poised to grow from USD 5.36 billion in 2023 to USD 6.64 billion by 2031, growing at a CAGR of 2.71% in the forecast period (2024-2031).

The global contrast agents' market is a dynamic sector within the medical imaging field, characterized by steady growth and technological advancements. Contrast agents play a pivotal role in enhancing the visibility of internal body structures during diagnostic imaging procedures, thereby facilitating accurate diagnoses and treatment planning across various medical specialties. As of recent analysis, the market has experienced notable expansion, driven primarily by the increasing prevalence of chronic diseases, the growing aging population, and the rising demand for advanced diagnostic techniques. Moreover, the continual innovation in contrast agent formulations, such as the development of safer and more effective agents with minimal side effects, has further propelled market growth. Notably, the market landscape is also shaped by evolving regulatory frameworks and healthcare policies, influencing product approvals, market entry strategies, and competitive dynamics. Across geographical regions, the contrast agents market exhibits non-uniform growth patterns, with developed economies like North America and Europe holding substantial market shares attributed to their robust healthcare infrastructure, high healthcare expenditure, and early adoption of advanced imaging technologies. Conversely, emerging economies in Asia-Pacific and Latin America present lucrative opportunities for market expansion, fueled by improving healthcare infrastructures, rising disposable incomes, and increasing investments in healthcare. However, challenges such as pricing pressures, stringent regulatory requirements, and the emergence of alternative imaging modalities pose significant obstacles to market players, necessitating strategic collaborations, product differentiation, and market penetration strategies to maintain competitiveness and sustain growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contrast Agents Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contrast Agents Market Segmental Analysis

The global contrast agents' market is segmented on the basis of application, product, modality and region. Based on application the market is segmented as, hospitals, clinics. Based on product the market is segmented as iodinated contrast media, microbubble contrast Media. Based on modality the market is segmented as ultrasound, X-ray/CT. Based on region the market is segmented as, North America, Europe, Asia-Pacific, MEA, and Latin America.

Drivers of the Global Contrast Agents Market

The global contrast agents market has experienced significant growth in recent years, driven by various factors such as technological advancements, increasing prevalence of chronic diseases, and rising demand for diagnostic imaging procedures. One notable driver of this market is the growing adoption of diagnostic imaging techniques across various medical fields, including radiology, cardiology, oncology, and neurology. Contrast agents play a crucial role in enhancing the visibility of internal body structures during imaging procedures such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound. With the continuous advancements in imaging technologies, there has been a greater emphasis on achieving higher resolution and improved diagnostic accuracy, thereby driving the demand for contrast agents.

Restraints in the Global Contrast Agents Market

However, despite the growth opportunities, the market also faces certain restraints, with one significant factor being the high cost associated with contrast agents and imaging procedures. The expense involved in acquiring imaging equipment, administering contrast agents, and interpreting imaging results can pose a financial burden on healthcare systems and patients alike. This cost factor may limit the accessibility of advanced imaging techniques, particularly in regions with limited healthcare infrastructure or economic constraints, thereby impeding market growth to some extent.

Market Trends of the Global Contrast Agents Market

On the other hand, a notable trend shaping the contrast agents' market is the increasing focus on the development of novel contrast agents with improved safety profiles and enhanced imaging properties. There is a growing demand for contrast agents that offer better tissue-specific targeting, reduced toxicity, and prolonged imaging enhancement, while also complying with stringent regulatory requirements. Manufacturers are investing in research and development activities to innovate new formulations, including nanoparticle-based agents, targeted contrast agents, and theranostic agents capable of both imaging and therapeutic functions. This trend underscores the ongoing efforts to address the evolving needs of healthcare professionals and patients, driving advancements in contrast agent technology and expanding the market's potential.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Contrast Agents Market by Application

Market Overview
Hospitals
Clinics

Global Contrast Agents Market by Product

Market Overview
Iodinated Contrast Media
Microbubble Contrast Media

Global Contrast Agents Market by Modality

Market Overview
Ultrasound
X-ray/CT

Global Contrast Agents Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
General Electric Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guerbet
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bracco Diagnostic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nano Therapeutics Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lantheus Medical Imaging, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
iMax
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trivitron Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hengrui Medicine
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
YRPG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BeiLu Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
J.B. Chemicals and Pharmaceuticals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Unijules Life Sciences Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SANOCHEMIA Pharmazeutika GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taejoon Pharm
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments